1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol has been researched along with misonidazole in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (49.00) | 18.7374 |
1990's | 48 (48.00) | 18.2507 |
2000's | 2 (2.00) | 29.6817 |
2010's | 1 (1.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, GE; Cole, S; Fielden, EM; Naylor, MA; O'Neill, P; Stephens, MA; Stratford, IJ; Threadgill, MD; Webb, P | 1 |
Adams, GE; Cole, S; Fielden, EM; Naylor, MA; O'Neill, P; Stephens, MA; Stratford, IJ; Threadgill, MD | 1 |
Adams, GE; Bremner, JC; Stratford, IJ; Wood, PJ | 1 |
Stratford, IJ | 1 |
Siemann, DW; Sutherland, RM | 1 |
Jenner, TJ; Maggi, A; O'Neill, P; Paone, A; Sapora, O | 1 |
Adams, GE; Bedwell, J; Bown, SG; Bremner, JC; MacRobert, AJ; Pearson, JK; Phillips, D; Sansom, JM; Stratford, IJ | 1 |
Beningo, KA; Elliott, WL; Heffner, TG; Leopold, WR; Sebolt-Leopold, JS; Stier, MA; Suto, MJ; Vincent, PW; Wiley, JN | 1 |
Scavone, SV; Sebolt-Leopold, JS | 1 |
Lafleur, MV; Loman, H; Retel, J; Soetekouw, R; Visser, OJ; Wagenaar, N; Westmijze, EJ | 2 |
Chaplin, DJ | 4 |
Durand, RE; Olive, PL | 1 |
Siemann, DW | 1 |
Adams, GE; Bremner, JC; Cole, S; Edwards, HS; Stratford, IJ | 1 |
Hall, EJ; He, ZY; Hei, TK; Piao, CQ | 2 |
Bridges, JM; Lappin, TR; MacManus, MP; McAleer, JJ; McKeown, SR | 1 |
Chaplin, DJ; Horsman, MR | 1 |
Adams, GE; Cole, S; Elliott, W; Fielden, EM; Leopold, W; Sebolt-Leopold, J; Stratford, IJ; Suto, M | 1 |
Binger, M; Workman, P | 1 |
Arundel-Suto, CM; Elliott, WE; Leopold, WR; Sebolt-Leopold, JS; Stier, MA; Suto, MJ; Werbel, LM | 1 |
Herman, TS; Holden, SA; Rudolph, MB; Teicher, BA | 1 |
Crump, PW; Fielden, EM; Jenner, TJ; O'Neill, P; Santodonato, L; Sapora, O | 1 |
Edwards, DI; Widdick, DA | 1 |
Adams, GE; Bremner, JC; Edwards, HS; Fielden, EM; Stratford, IJ | 1 |
Koch, CJ; Wallen, CA; Wheeler, KT; Wong, KH | 1 |
Adams, GE; Bowler, J; Cole, S; Lorimore, SA; Nolan, J; Stratford, IJ; Wright, EG | 1 |
Adams, GE; Bowler, J; Bremner, JC; Stratford, IJ | 1 |
Adams, GE; Godden, J; Keohane, A; Stratford, IJ | 1 |
Adams, GE; Cole, S; Fielden, EM; Jenkins, TC; Stratford, IJ | 1 |
Hall, EJ; Pirro, JP; Roizin-Towle, L | 1 |
Butler, SA; Cobb, LM; Nolan, J | 1 |
Crump, PW; Fielden, EM; Jenner, TJ; O'Neill, P | 1 |
Adams, GE; Cole, S; Fielden, EM; Jenkins, TC; Naylor, MA; O'Neill, P; Stier, MA; Stratford, IJ; Suto, MJ; Threadgill, MD | 1 |
Hall, EJ; Hei, TK | 1 |
Hickson, ID; Robson, CN; Stephens, M; Stratford, IJ | 1 |
Deacon, J; Holliday, S; Stratford, IJ; Walling, JM | 1 |
Adams, GE; Godden, J; Howells, N; Stratford, IJ | 1 |
Adams, GE; Cole, S; Stratford, IJ | 1 |
Cole, S; Robbins, L | 1 |
Cunniffe, SM; O'Neill, P | 1 |
Biol, GI; Dale, LD; Edwards, DI; Widdick, DA | 1 |
Gulyas, S; Hill, RP; Whitmore, GF | 2 |
Chapman, JD; Kanclerz, A | 1 |
Brown, JM | 1 |
Bush, C; Delic, JI; Schlappack, OK; Stanley, JA; Steel, GG | 1 |
Kennedy, KA | 1 |
Dische, S | 1 |
Walton, MI; Workman, P | 2 |
Fielden, EM; Jenner, TJ; O'Neill, P; Sapora, O | 1 |
Dale, LD; Edwards, DI; Tocher, JH | 1 |
Chaplin, DJ; Horsman, MR; Overgaard, J | 1 |
Adams, GE; Stephens, MA; Stratford, IJ; Walling, J | 1 |
Adams, GE; Ahmed, I; Fielden, EM; Jenkins, TC; McNeil, SS; O'Neill, P; Silver, AR; Stratford, IJ | 1 |
Austen, KR; Fielden, EM; Jenner, TJ; O'Neill, P | 1 |
Deacon, JM; Holliday, SB; Horwich, A; Peckham, MJ | 1 |
Acker, B; Chaplin, DJ | 1 |
Jenkins, TC; McNeil, SS; O'Neill, P | 1 |
Chaplin, DJ; Durand, RE; Olive, PL | 1 |
Adams, GE; O'Neill, P; Sheldon, PW; Silver, AR; Stratford, IJ; Walling, JM | 1 |
O'Neill, P; Silver, AR | 1 |
Silver, AR; Stratford, IJ; Walling, JM | 1 |
Workman, P | 1 |
Adams, GE; Ahmed, I; Fielden, EM; Jenkins, TC; Sheldon, PW; Stratford, IJ; Walling, JM | 1 |
Adams, GE; Ahmed, I; Fielden, EM; Jenkins, TC; Silver, AR; Stratford, IJ; Walling, JM | 1 |
Ahmed, I; Deacon, JM; Holliday, SB; Jenkins, TC | 1 |
Chaplin, DJ; Durand, RE; Jenkins, TC; Stratford, IJ | 1 |
Jenkins, TC; McNeil, SS; O'Neill, P; Silver, AR | 1 |
Gulyas, S; Whitmore, GF | 1 |
Ahmed, I; Jenkins, TC; McNeil, SS; O'Neill, P; Silver, AR | 1 |
Geard, CR; Hall, EJ; Hei, TK; Osmak, RS | 1 |
Alliet, K; Maddison, K; Siemann, DW; Wolf, K | 1 |
Jenkins, TC; O'Neill, P; Silver, AR | 1 |
Adams, GE | 1 |
Adams, GE; Ahmed, I; Sheldon, PW; Stratford, IJ | 2 |
Edwards, DI; Knight, RC; Knox, RJ; Skolimowski, IM; Zahoor, A | 1 |
Maddison, K; Siemann, DW; Wolf, K | 1 |
Olive, PL | 2 |
Adams, GE; Bradley, JK; Bremner, JC; Naylor, MA; Sansom, JM; Stratford, IJ | 1 |
Adams, GE; Fielden, EM; Naylor, MA; Showalter, HD; Stephens, MA; Stratford, IJ; Threadgill, MD | 1 |
Koch, CJ | 1 |
Bremner, JC | 1 |
Stratford, IJ; Workman, P | 1 |
Bengmark, S; Persson, BG; Wang, LQ | 1 |
Adams, GE; Horsman, MR; Khalil, AA; Overgaard, J; Steinberg, F; Stratford, IJ; Streffer, C; Wood, PJ | 1 |
Olive, PL; Zheng, H | 1 |
Dachs, GU; Firth, JD; Harris, AL; Patterson, AV; Ratcliffe, PJ; Stratford, IJ; Townsend, KM | 1 |
Chinje, EC; Harris, AL; Patterson, AV; Saunders, MP; Strafford, IJ; Talbot, DC | 1 |
Melo, T; Misra, V; Rauth, AM | 1 |
Airley, R; Cowen, RL; Honess, D; Jaffar, M; Patterson, AV; Saunders, M; Stratford, IJ; Telfer, BA; van der Kogel, AJ; Williams, KJ; Wolf, CR | 1 |
BanĂ¡th, JP; Durand, RE; Olive, PL | 1 |
Elliott, W; Leopold, J; Leopold, W; Sercel, A; Showalter, H; Suto, C; Winters, T | 1 |
6 review(s) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and misonidazole
Article | Year |
---|---|
Bioreductive drugs in cancer therapy.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Hypoxia; Humans; Misonidazole; Neoplasms; Nitroimidazoles; Prodrugs; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1992 |
Sensitizers and protectors in radiotherapy.
Topics: Amifostine; Animals; Aziridines; Clinical Trials as Topic; Drug Evaluation; Etanidazole; Glutathione; Humans; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy | 1985 |
Hypoxic cells as specific drug targets for chemotherapy.
Topics: Animals; Antineoplastic Agents; DNA Damage; DNA Repair; Humans; Misonidazole; Mitomycin; Mitomycins; Oxygen; Tirapazamine; Triazines | 1987 |
Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanidazole; Humans; Metronidazole; Misonidazole; Neoplasms; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1985 |
Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Survival; Humans; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents | 1993 |
The experimental development of bioreductive drugs and their role in cancer therapy.
Topics: Animals; Antineoplastic Agents; Aziridines; Combined Modality Therapy; DNA Damage; Humans; Indolequinones; Indoles; Misonidazole; Neoplasms; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1993 |
3 trial(s) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and misonidazole
Article | Year |
---|---|
Sensitizers and protectors in radiotherapy.
Topics: Amifostine; Animals; Aziridines; Clinical Trials as Topic; Drug Evaluation; Etanidazole; Glutathione; Humans; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy | 1985 |
Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Etanidazole; Humans; Metronidazole; Misonidazole; Neoplasms; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1985 |
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069.
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Kinetics; Middle Aged; Misonidazole; Nausea; Radiation-Sensitizing Agents; Vomiting | 1986 |
93 other study(ies) available for 1-(2-nitro-1-imidazolyl)-3-aziridino-2-propanol and misonidazole
Article | Year |
---|---|
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Mice; Nitro Compounds; Radiation-Sensitizing Agents; Sarcoma, Experimental; Structure-Activity Relationship; Thiophenes | 1991 |
Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins.
Topics: Amides; Animals; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Cricetinae; Cricetulus; Cytotoxins; Mice; Mice, Inbred C3H; Nitrofurans; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1990 |
Can 31P magnetic resonance spectroscopy measurements of changes in experimental tumour metabolism be related to modification of oxygenation status?
Topics: Animals; Cell Hypoxia; Magnetic Resonance Spectroscopy; Mice; Misonidazole; Neoplasms, Experimental; Phosphorus; Radiation-Sensitizing Agents; Time Factors | 1992 |
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured | 1992 |
Induction of mutations in V79-4 mammalian cells under hypoxic and aerobic conditions by the cytotoxic 2-nitroimidazole-aziridines, RSU-1069 and RSU-1131. The influence of cellular glutathione.
Topics: Animals; Aziridines; Buthionine Sulfoximine; Cell Hypoxia; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Glutathione; Methionine Sulfoximine; Misonidazole; Mutagenicity Tests; Mutation; Oxidation-Reduction; Oxygen; Thioguanine | 1992 |
Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.
Topics: Animals; Indoles; Mice; Misonidazole; Nitroimidazoles; Organometallic Compounds; Photochemotherapy; Sarcoma; Tumor Cells, Cultured | 1992 |
Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agents.
Topics: Animals; Antiemetics; Dogs; Drug Evaluation; Imidazoles; Mice; Misonidazole; Nitroimidazoles; Ondansetron; Radiation-Sensitizing Agents; Vomiting | 1992 |
Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.
Topics: Alkylating Agents; Animals; Carmustine; Drug Synergism; In Vitro Techniques; Isoquinolines; Leukemia L1210; Misonidazole; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin; Tumor Cells, Cultured | 1992 |
Inactivation and repair of double-stranded DNA damaged by the aziridinyl nitroimidazole RSU 1069.
Topics: Alkalies; Antineoplastic Agents; Bacteriophage phi X 174; DNA; DNA Damage; DNA Repair; DNA, Viral; Electrolytes; Hydrogen-Ion Concentration; Misonidazole; Radiation-Sensitizing Agents | 1992 |
Bioreductive therapy.
Topics: Antineoplastic Agents; Cell Hypoxia; Humans; Misonidazole; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1992 |
Evaluation of bioreductive drugs in multicell spheroids.
Topics: Animals; Antineoplastic Agents; Cell Aggregation; Cell Hypoxia; Cell Survival; Cricetinae; Evaluation Studies as Topic; In Vitro Techniques; Misonidazole; Mitomycin; Models, Biological; Nitrofurans; Porfiromycin; Prodrugs; Tirapazamine; Triazines | 1992 |
Cytotoxicity of dual function nitrofurans in rodent and human tumor cells.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; Cell Survival; Dose-Response Relationship, Drug; Humans; Mice; Misonidazole; Nitrofurans; Prodrugs; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1992 |
Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue EO9.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Indolequinones; Indoles; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Prodrugs; Tirapazamine; Triazines | 1992 |
Mechanism of oncogenicity for bioreductive drugs.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; Cell Line; Cell Transformation, Neoplastic; Mice; Misonidazole; Neoplasms, Second Primary; Nitrofurans; Prodrugs; Radiation-Sensitizing Agents; Risk; Tirapazamine; Triazines | 1992 |
Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
Topics: Animals; Biotransformation; Cell Hypoxia; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Mice, Inbred Strains; Misonidazole; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1992 |
Tumor blood flow changes induced by chemical modifiers of radiation response.
Topics: Animals; Antineoplastic Agents; Blood Flow Velocity; Cisplatin; Doxorubicin; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1992 |
Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Drug Evaluation; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1992 |
Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Female; Half-Life; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Prodrugs; Sarcoma, Experimental | 1991 |
Interaction of RSU 1069 and 1137 with DNA in vitro. Biological implications and mechanistic aspects.
Topics: Alkalies; Aziridines; Bacteriophage phi X 174; DNA; DNA Damage; DNA, Single-Stranded; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Misonidazole; Temperature | 1991 |
A new class of analogues of the bifunctional radiosensitizer alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines.
Topics: Animals; Aziridines; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; Cricetinae; Fibrosarcoma; Mice; Misonidazole; Molecular Structure; Nitroimidazoles; Oxygen; Pyrans; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1991 |
Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
Topics: Animals; Benzimidazoles; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Fibrosarcoma; Fluorescent Dyes; Hydrogen-Ion Concentration; Hyperthermia, Induced; Male; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1991 |
The repair of DNA damage induced in V79 mammalian cells by the nitroimidazole-aziridine, RSU-1069. Implications for radiosensitization.
Topics: Animals; Cell Line; Cricetinae; Cricetulus; DNA; DNA Damage; DNA Repair; Dose-Response Relationship, Radiation; Kinetics; Misonidazole; Radiation-Sensitizing Agents; Temperature | 1991 |
A comparison of the relative activities of 8 radiosensitizers in the SOS chromotest.
Topics: Cell Hypoxia; Escherichia coli; Misonidazole; Radiation-Sensitizing Agents; SOS Response, Genetics | 1991 |
Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
Topics: Antineoplastic Agents; Combined Modality Therapy; Humans; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents | 1991 |
Pharmacokinetics and cytotoxicity of RSU-1069 in subcutaneous 9L tumours under oxic and hypoxic conditions.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Injections, Subcutaneous; Male; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Rats; Rats, Inbred F344; Tumor Stem Cell Assay | 1991 |
Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
Topics: Administration, Oral; Animals; Combined Modality Therapy; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1991 |
Bioreductive drugs and the selective induction of tumour hypoxia.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Constriction; Hydralazine; Mice; Mice, Inbred C3H; Misonidazole; Mitomycin; Mitomycins; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tirapazamine; Triazines | 1990 |
The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line; Cell Survival; Misonidazole; Mitomycin; Mitomycins; Radiation Tolerance; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1990 |
Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Topics: Animals; Antineoplastic Agents; Female; Mice; Mice, Inbred C3H; Misonidazole; Prodrugs; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1990 |
Studies with bifunctional bioreductive drugs. I. In vitro oncogenic transforming potential.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents | 1990 |
Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
Topics: Antineoplastic Agents; Aziridines; Cell Line; Cell Survival; Humans; In Vitro Techniques; Lung Neoplasms; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents | 1990 |
Distribution of pimonidazole and RSU 1069 in tumour and normal tissues.
Topics: Animals; Antineoplastic Agents; Autoradiography; Male; Melanins; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Tissue Distribution | 1990 |
A comparison of the techniques of alkaline filter elution and alkaline sucrose sedimentation used to assess DNA damage induced by 2-nitroimidazoles.
Topics: Animals; Cell Line; Centrifugation, Density Gradient; Cricetinae; DNA; DNA Damage; Fibroblasts; Filtration; Hydrogen-Ion Concentration; Misonidazole; Oxygen | 1990 |
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activate
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytotoxins; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Prodrugs; Radiation-Sensitizing Agents | 1990 |
Oncogenic transforming potential of nitroimidazole radiosensitizers.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Etanidazole; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1989 |
Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Etanidazole; Glutathione Transferase; Melphalan; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1989 |
High uptake of RSU 1069 and its analogues melanotic melanomas.
Topics: Animals; Cell Line; Cell Membrane Permeability; Deoxyribonucleases; Drug Evaluation, Preclinical; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred Strains; Microbial Collagenase; Misonidazole; Sarcoma, Experimental; Tissue Distribution; Trypsin; Tumor Cells, Cultured | 1989 |
Induction of tumour hypoxia post-irradiation: a method for increasing the sensitizing efficiency of misonidazole and RSU 1069 in vivo.
Topics: Animals; Combined Modality Therapy; Female; Hydralazine; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radiation-Sensitizing Agents | 1989 |
Manipulation of radiobiological hypoxia in a human melanoma xenograft to exploit the bioreductive cytotoxicity of RSU-1069.
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Constriction; Female; Hydralazine; Melanoma; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1989 |
Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine: effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzaldehydes; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Hydralazine; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Oxidation-Reduction; Oxygen; Radiation-Sensitizing Agents; Radiotherapy; Transplantation, Heterologous | 1989 |
Assessment of the repair and damage of DNA induced by parent and reduced RSU-1069, a 2-nitroimidazole-aziridine.
Topics: Aerobiosis; Antineoplastic Agents; DNA Damage; DNA Repair; Escherichia coli; Misonidazole; Oxidation-Reduction; Plasmids; Radiation-Sensitizing Agents; Transcription, Genetic | 1989 |
Comparative DNA damage and repair induced by misonidazole, CB 1954 and RSU 1069.
Topics: Antineoplastic Agents; Aziridines; Azirines; Coliphages; DNA Damage; DNA Repair; DNA, Bacterial; DNA, Single-Stranded; DNA, Viral; Escherichia coli; Misonidazole; Radiation-Sensitizing Agents | 1989 |
Toxicity of RSU-1069 for KHT cells treated in vivo or in vitro: evidence for a diffusible toxic product.
Topics: Animals; Cell Count; Cell Survival; Diffusion; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental; Tumor Cells, Cultured | 1989 |
Hydralazine-induced tumor hypoxia: a potential target for cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Aziridines; Drug Synergism; Female; Hydralazine; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Misonidazole; Mitomycins; Neoplasms, Experimental; Regional Blood Flow | 1989 |
Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Topics: Amifostine; Animals; Etanidazole; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1988 |
The response of murine stem spermatogonia to radiation combined with 3-aminobenzamide.
Topics: Animals; Benzamides; Colony-Forming Units Assay; DNA Repair; Gamma Rays; Male; Mice; Mice, Inbred CBA; Misonidazole; Oxygen; Poly(ADP-ribose) Polymerase Inhibitors; Radiation Tolerance; Radiation-Sensitizing Agents; Spermatogenesis; Spermatogonia; Spermatozoa; Stem Cells | 1987 |
Pharmacokinetics and metabolism of the mixed-function hypoxic cell sensitizer prototype RSU 1069 in mice.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Chromatography, High Pressure Liquid; Female; Fibrosarcoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Radiation-Sensitizing Agents | 1988 |
Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
Topics: Antineoplastic Agents; Cell Survival; Cells, Cultured; Cross-Linking Reagents; DNA; DNA Damage; Misonidazole; Oxidation-Reduction; Oxygen; Radiation-Sensitizing Agents | 1988 |
Comparative DNA damage induced by nitroimidazole-aziridine drugs: 1. Effects of methyl substitution on drug action.
Topics: Coliphages; DNA Damage; DNA, Single-Stranded; DNA, Viral; Misonidazole; Molecular Structure; Oxidation-Reduction; Polarography; Structure-Activity Relationship | 1988 |
The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
Topics: Animals; Combined Modality Therapy; Female; Hydralazine; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Misonidazole | 1988 |
Dual-function radiation sensitizers and bioreductive drugs: factors affecting cellular uptake and sensitizing efficiency in analogues of RSU 1069.
Topics: Animals; Cell Line; Cricetinae; Misonidazole; Radiation-Sensitizing Agents | 1988 |
Postirradiation modification of tumor blood flow: a method to increase the effectiveness of chemical radiosensitizers.
Topics: Animals; Cell Survival; Combined Modality Therapy; Female; Hydralazine; Lung Neoplasms; Mice; Mice, Inbred C57BL; Misonidazole; Radiation-Sensitizing Agents; Regional Blood Flow; Vasodilator Agents | 1988 |
Mechanism of action of some bioreducible 2-nitroimidazoles: comparison of in vitro cytotoxicity and ability to induce DNA strand breakage.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; DNA; DNA Damage; Misonidazole; Nitroimidazoles; Oxidation-Reduction; Plasmids; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1987 |
Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; In Vitro Techniques; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1987 |
The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain.
Topics: Animals; Cell Survival; Cells, Cultured; Female; Hydralazine; Lung Neoplasms; Mice; Mice, Inbred C57BL; Misonidazole; Radiation-Sensitizing Agents | 1987 |
Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131.
Topics: Deoxyribonucleotides; DNA; DNA Damage; Kinetics; Misonidazole; Plasmids; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1987 |
Cytotoxicity of RSU 1069 in spheroids and murine tumors.
Topics: Animals; Cell Survival; Cricetinae; In Vitro Techniques; Mice; Misonidazole; Models, Biological; Neoplasms, Experimental; Oxygen; Radiation-Sensitizing Agents | 1987 |
RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; DNA; Female; Glutathione; Hydrolysis; Hypoxia; Kinetics; Misonidazole; Oxidation-Reduction; Radiation-Sensitizing Agents; Structure-Activity Relationship; X-Rays | 1986 |
Interaction of the aziridine moiety of RSU-1069 with nucleotides and inorganic phosphate. Implications for alkylation of DNA.
Topics: Adamantane; Alkylation; Animals; Chromatography, Liquid; Deoxyguanine Nucleotides; DNA; Hydrogen-Ion Concentration; Kinetics; Mathematics; Misonidazole; Nucleotides; Osmolar Concentration; Phosphates | 1986 |
The differential cytotoxicity of RSU 1069: cell survival studies indicating interaction with DNA as a possible mode of action.
Topics: Animals; Benzamides; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Cricetinae; DNA; Dose-Response Relationship, Drug; Glutathione; Misonidazole; NAD; Oxygen; Radiation-Sensitizing Agents | 1986 |
Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Drug; HeLa Cells; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radiation Tolerance | 1986 |
Chemosensitization of lomustine by misonidazole, benznidazole, and RSU 1069.
Topics: Animals; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1986 |
Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
Topics: Animals; Cell Line; Cell Survival; Combined Modality Therapy; Cricetinae; In Vitro Techniques; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents | 1986 |
Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
Topics: Animals; Cell Line; Cell Survival; Cricetinae; In Vitro Techniques; Misonidazole; Radiation-Sensitizing Agents | 1986 |
Experimental pharmacokinetics of RSU-1069 and its analogues: high tumor/plasma ratios.
Topics: Animals; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Transplantation; Radiation-Sensitizing Agents | 1986 |
The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
Topics: Animals; Cell Survival; Combined Modality Therapy; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Oxygen; Radiation-Sensitizing Agents | 1986 |
The phosphate-group of DNA as a potential target for RSU-1069, a nitroimidazole-aziridine radiosensitizer.
Topics: DNA, Bacterial; Misonidazole; Plasmids; Radiation-Sensitizing Agents | 1986 |
Studies on the toxicity of RSU-1069.
Topics: Aerobiosis; Anaerobiosis; Animals; Cell Line; Cell Survival; Cricetinae; In Vitro Techniques; Misonidazole; Mutation; Radiation-Sensitizing Agents | 1986 |
Induction of DNA strand breaks by reduced nitroimidazoles. Implications for DNA base damage.
Topics: Deoxyguanosine; DNA; DNA Damage; Glyoxal; Misonidazole; Nitroimidazoles; Oxidation-Reduction; Structure-Activity Relationship | 1986 |
Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT).
Topics: Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Misonidazole; Serotonin | 1986 |
In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; In Vitro Techniques; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sister Chromatid Exchange; Time Factors | 1985 |
Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Lethal Dose 50; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Radiation-Protective Agents; Sarcoma | 1985 |
Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizer. Role of binding of both unreduced and radiation-reduced forms to DNA, in vitro.
Topics: Acetates; Animals; Buffers; Cattle; DNA; DNA, Bacterial; Drug Stability; Escherichia coli; Hydrogen-Ion Concentration; Kinetics; Misonidazole; Oxidation-Reduction; Phosphates; Plasmids; Radiation-Protective Agents; Spectrophotometry; Thymus Gland | 1985 |
Radiosensitizers: a conference preview.
Topics: Animals; Aziridines; Buthionine Sulfoximine; Carmustine; Combined Modality Therapy; Drug Synergism; Etanidazole; Humans; Ketones; Lomustine; Maleates; Methionine Sulfoximine; Mice; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo.
Topics: Animals; Aziridines; Azirines; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Radiation; Drug Synergism; Female; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Neoplasms, Experimental; Oxygen; Radiation-Sensitizing Agents | 1984 |
Pharmacology of the mixed-function radio- and chemosensitizers CB 1954 and RSU 1069.
Topics: Animals; Aziridines; Azirines; Brain; Drug Synergism; Female; Male; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Time Factors | 1984 |
Photosensitive interaction of RSU 1069 with DNA.
Topics: Aziridines; Azirines; Darkness; DNA; Light; Misonidazole; Radiation-Sensitizing Agents | 1984 |
RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Cell Line; Cell Survival; Combined Modality Therapy; Cricetinae; Cricetulus; Drug Synergism; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasms, Experimental; Radiation-Sensitizing Agents | 1984 |
Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Topics: Animals; Aziridines; Azirines; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; Time Factors | 1984 |
Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
Topics: Aerobiosis; Animals; Antineoplastic Agents; Bone Marrow; Carcinoma, Squamous Cell; Cell Hypoxia; DNA Damage; DNA, Single-Stranded; Dose-Response Relationship, Radiation; Electrophoresis, Agar Gel; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred C3H; Misonidazole; Organ Specificity; Oxidation-Reduction; Radiation-Sensitizing Agents; Spleen; Tirapazamine; Triazines | 1995 |
Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cells, Cultured; Cricetinae; Cricetulus; DNA; DNA Damage; DNA Repair; DNA, Neoplasm; Fibroblasts; Flow Cytometry; Kinetics; Male; Mice; Mice, Inbred C3H; Misonidazole | 1995 |
Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT).
Topics: Animals; Antineoplastic Agents; Mice; Mice, Inbred C3H; Misonidazole; Mitomycin; Nitroimidazoles; Photochemotherapy; Sarcoma, Experimental | 1994 |
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro.
Topics: Antineoplastic Agents; Misonidazole; Nitroimidazoles; Prodrugs; Radiation-Sensitizing Agents; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |
Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
Topics: Animals; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Fibroblasts; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1993 |
Bioreduction of RSU 1069 and mitomycin C after dearterialization.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Chemotherapy, Adjuvant; Hepatic Artery; Humans; Ligation; Liver Neoplasms, Experimental; Male; Misonidazole; Mitomycin; Rats; Rats, Inbred WF | 1993 |
A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C3H; Misonidazole; Neovascularization, Pathologic; Nitroimidazoles; Oxygen; Phosphorus Radioisotopes | 1996 |
Influence of oxygen on radiation-induced DNA damage in testicular cells of C3H mice.
Topics: Animals; DNA; DNA Damage; DNA Repair; Hypoxia; Male; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Sertoli Cells; Spermatids; Spermatocytes; Spleen; Testis; Tumor Cells, Cultured | 1997 |
Targeting gene expression to hypoxic tumor cells.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Hypoxia; Cytosine Deaminase; DNA-Binding Proteins; Fibrosarcoma; Flucytosine; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Misonidazole; Neoplasm Transplantation; Nuclear Proteins; Nucleoside Deaminases; Oxygen; Phosphoglycerate Kinase; Prodrugs; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcription Factors; Tumor Cells, Cultured | 1997 |
Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Misonidazole; NADPH-Ferrihemoprotein Reductase; Radiation-Sensitizing Agents; Tirapazamine; Transfection; Triazines; Tumor Cells, Cultured | 1997 |
Bioreductive therapies: an overview of drugs and their mechanisms of action.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; DNA, Neoplasm; Forecasting; Humans; Indolequinones; Indoles; Misonidazole; Mitomycin; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1998 |
Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.
Topics: Animals; Combined Modality Therapy; Female; Fibrosarcoma; Genetic Therapy; Genetic Vectors; Humans; Hypoxia; Mice; Mice, Nude; Misonidazole; NADPH-Ferrihemoprotein Reductase; Neoplasm Transplantation; Nitroimidazoles; Prodrugs; Radiation Tolerance; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
The range of oxygenation in SiHa tumor xenografts.
Topics: Animals; Carcinoma; Cell Survival; Comet Assay; DNA Damage; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Misonidazole; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2002 |
Design and synthesis of 2-nitroimidazoles with variable alkylating and acylating functionality.
Topics: Acylation; Alkylating Agents; Animals; Drug Design; Drug Screening Assays, Antitumor; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship | 2014 |